Medios AGFRA:ILM1 +2.18%88 PB Ratio is 0.60 as of Jul. 05, 2026, which is 35% below its 10-year median of 0.92. GuruFocus rates FRA:ILM1 with a GF Score™ of 88/100 and a GF Value™ of €17.16 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 110 Medical Distribution companies, Medios AG ranks better than 84.55% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-05), Medios AG's share price is €12.20. Medios AG's Book Value per Share for the quarter that ended in Mar. 2026 was €20.38. Hence, Medios AG's PB Ratio of today is 0.60.
Good Sign:
Medios AG stock PB Ratio (=0.6) is close to 10-year low of 0.54.
The historical rank and industry rank for Medios AG's PB Ratio or its related term are showing as below:
FRA:ILM1'
s PB Ratio Range Over the Past 10 Years
Min: 0.54 Med: 0.92 Max: 5.87
Current: 0.6
During the past 13 years, Medios AG's highest PB Ratio was 5.87. The lowest was 0.54. And the median was 0.92.
FRA:ILM1's PB Ratio is ranked better than 84.55% of 110
companies
in the Medical Distribution industry
Industry Median: 1.02
vs FRA:ILM1: 0.60
During the past 12 months, Medios AG's average Book Value Per Share Growth Rate was 0.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 14.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 32.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medios AG was 414.40% per year. The lowest was -54.40% per year. And the median was 38.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medios AG PB Ratio Related Terms
Medios AG PB Ratio Historical Data
* Premium members only.
The historical data trend for Medios AG's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medios AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medios AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Medios AG's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medios AG (FRA:ILM1) has a PB Ratio of 0.60 as of Jul. 05, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medios AG and its competitors. This is 35% below median its historical median of 0.92. Over the past decade, Medios AG's PB Ratio has ranged from 0.54 to 5.87. According to the industry distribution chart, Medios AG ranks #17 out of 110 companies in the Medical Distribution industry, placing it in the top 15.5%.
Is Medios AG's PB Ratio too high?
Medios AG's current PB Ratio of 0.60 is 35% below median its 10-year median of 0.92. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 5.87. The Medical Distribution industry median PB Ratio is 1.02. Medios AG's value of 0.60 is 41.2% below this industry median. Based on the distribution chart, Medios AG ranks #17 out of 110 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medios AG has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medios AG's PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medios AG ranks #17 out of 110 companies for PB Ratio. This places Medios AG in the top 16% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.02. Medios AG's value of 0.60 is 41.2% below this benchmark. Historically, Medios AG's own PB Ratio has ranged from 0.54 to 5.87 over the past decade. While the company's 10-year median is 0.92 vs. the industry median of 1.02, Medios AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.02, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current PB Ratio of 0.60 is 41.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current PB Ratio is 0.60, which is 35% below median its own 10-year median of 0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Based on GuruFocus' analysis, Medios AG (FRA:ILM1) is currently considered Modestly Undervalued. The stock's GF Value™ is €17.16, compared to a current price of €12.20 — trading 28.9% below its estimated fair value. The current PB Ratio is 0.60, which is 35% below median its 10-year median of 0.92 and 41.2% below the Medical Distribution industry median of 1.02. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medios AG (FRA:ILM1), the current PB Ratio is 0.60 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (FRA:ILM1) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of €12.20 is trading 28.9% below its estimated GF Value™ of €17.16.
GuruFocus considers Medios AG to be Modestly Undervalued.
Key valuation signals for FRA:ILM1:
PB Ratio: 0.60 (35% below median its 10-year median of 0.92)
GF Value™: €17.16 vs. price of €12.20 (28.9% below fair value)
Industry Position: 41.2% below the Medical Distribution median (#17 of 110)
No single metric tells the full story. See the FRA:ILM1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for FRA:ILM1
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ILM1 has been successfully added to your 
